# ManpowerGroup Inc.: financial statements, quarterly

MAN · NYSE · CIK 871763 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/man.md) · [Financials](/companies/man/financials.md) · [Filings](/companies/man/filings.md) · [Insiders](/companies/man/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/man/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,676](/filings/0000950170-24-124196.md) | [4,631 d](/filings/0001193125-26-064113.md) | [4,403](/filings/0000950170-25-062835.md) | [4,521](/filings/0000950170-25-103114.md) | [4,530](/filings/0001193125-25-260851.md) | [4,400 d](/filings/0001193125-26-064113.md) | [4,090](/filings/0001193125-26-215064.md) | [4,519](/filings/0001193125-26-340522.md) | [4,634](/filings/0001193125-25-260851.md) | [4,713 d](/filings/0001193125-26-064113.md) | [4,510](/filings/0001193125-26-215064.md) | [4,860](/filings/0001193125-26-340522.md) |
| Cost of revenue | $m | [3,854](/filings/0000950170-24-124196.md) | [3,820 d](/filings/0001193125-26-064113.md) | [3,640](/filings/0000950170-25-062835.md) | [3,735](/filings/0000950170-25-103114.md) | [3,748](/filings/0001193125-25-260851.md) | [3,645 d](/filings/0001193125-26-064113.md) | [3,392](/filings/0001193125-26-215064.md) | [3,756](/filings/0001193125-26-340522.md) | [3,866](/filings/0001193125-25-260851.md) | [3,946 d](/filings/0001193125-26-064113.md) | [3,787](/filings/0001193125-26-215064.md) | [4,080](/filings/0001193125-26-340522.md) |
| Gross profit | $m | [822](/filings/0000950170-24-124196.md) | [811 d](/filings/0001193125-26-064113.md) | [764](/filings/0000950170-25-062835.md) | [786](/filings/0000950170-25-103114.md) | [782](/filings/0001193125-25-260851.md) | [755 d](/filings/0001193125-26-064113.md) | [698](/filings/0001193125-26-215064.md) | [764](/filings/0001193125-26-340522.md) | [769](/filings/0001193125-25-260851.md) | [767 d](/filings/0001193125-26-064113.md) | [723](/filings/0001193125-26-215064.md) | [780](/filings/0001193125-26-340522.md) |
| Selling, general and administrative | $m | [752](/filings/0000950170-24-124196.md) | [850 d](/filings/0001193125-26-064113.md) | [698](/filings/0000950170-25-062835.md) | [685](/filings/0000950170-25-103114.md) | [711](/filings/0001193125-25-260851.md) | [687 d](/filings/0001193125-26-064113.md) | [670](/filings/0000950170-25-062835.md) | [789](/filings/0001193125-26-340522.md) | [702](/filings/0001193125-25-260851.md) | [686 d](/filings/0001193125-26-064113.md) | not reported | [668](/filings/0001193125-26-340522.md) |
| Operating income | $m | [69.8](/filings/0000950170-24-124196.md) | [(39.5) d](/filings/0001193125-26-064113.md) | [65.9](/filings/0000950170-25-062835.md) | [101](/filings/0000950170-25-103114.md) | [70.8](/filings/0001193125-25-260851.md) | [68.2 d](/filings/0001193125-26-064113.md) | [28.2](/filings/0001193125-26-215064.md) | [(25.3)](/filings/0001193125-26-340522.md) | [66.6](/filings/0001193125-25-260851.md) | [80.6 d](/filings/0001193125-26-064113.md) | [28.3](/filings/0001193125-26-215064.md) | [112](/filings/0001193125-26-340522.md) |
| Interest expense | $m | [21.0](/filings/0000950170-24-124196.md) | [(139) d](/filings/0001193125-26-064113.md) | [20.4](/filings/0000950170-25-062835.md) | [22.0](/filings/0000950170-25-103114.md) | [24.6](/filings/0001193125-25-260851.md) | [(157) d](/filings/0001193125-26-064113.md) | [22.5](/filings/0001193125-26-215064.md) | [26.0](/filings/0001193125-26-340522.md) | [24.0](/filings/0001193125-25-260851.md) | [(168) d](/filings/0001193125-26-064113.md) | [25.7](/filings/0001193125-26-215064.md) | [23.8](/filings/0001193125-26-340522.md) |
| Income tax | $m | [24.4](/filings/0000950170-24-124196.md) | [29.5 d](/filings/0001193125-26-064113.md) | [17.8](/filings/0000950170-25-062835.md) | [32.3](/filings/0000950170-25-103114.md) | [36.4](/filings/0001193125-25-260851.md) | [25.2 d](/filings/0001193125-26-064113.md) | [11.1](/filings/0001193125-26-215064.md) | [25.3](/filings/0001193125-26-340522.md) | [34.9](/filings/0001193125-25-260851.md) | [35.4 d](/filings/0001193125-26-064113.md) | [12.9](/filings/0001193125-26-215064.md) | [38.9](/filings/0001193125-26-340522.md) |
| Net income | $m | [30.3](/filings/0000950170-24-124196.md) | [(84.5) d](/filings/0001193125-26-064113.md) | [39.7](/filings/0001193125-25-260851.md) | [60.1](/filings/0001193125-25-260851.md) | [22.8](/filings/0001193125-25-260851.md) | [22.5 d](/filings/0001193125-26-064113.md) | [5.6](/filings/0001193125-26-340522.md) | [(67.1)](/filings/0001193125-26-340522.md) | [18.0](/filings/0001193125-25-260851.md) | [30.2 d](/filings/0001193125-26-064113.md) | [2.5](/filings/0001193125-26-340522.md) | [53.5](/filings/0001193125-26-340522.md) |
| Diluted EPS | $ per share | [0.60](/filings/0000950170-24-124196.md) | not reported | [0.81](/filings/0000950170-25-062835.md) | [1.24](/filings/0000950170-25-103114.md) | [0.47](/filings/0001193125-25-260851.md) | not reported | [0.12](/filings/0001193125-26-215064.md) | [(1.44)](/filings/0001193125-26-340522.md) | [0.38](/filings/0001193125-25-260851.md) | not reported | [0.05](/filings/0001193125-26-215064.md) | [1.13](/filings/0001193125-26-340522.md) |
| Basic EPS | $ per share | [0.61](/filings/0000950170-24-124196.md) | not reported | [0.82](/filings/0000950170-25-062835.md) | [1.25](/filings/0000950170-25-103114.md) | [0.48](/filings/0001193125-25-260851.md) | not reported | [0.12](/filings/0001193125-26-215064.md) | [(1.44)](/filings/0001193125-26-340522.md) | [0.39](/filings/0001193125-25-260851.md) | not reported | [0.05](/filings/0001193125-26-215064.md) | [1.14](/filings/0001193125-26-340522.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [571](/filings/0000950170-23-058839.md) | [581](/filings/0000950170-25-023186.md) | [605](/filings/0000950170-24-052961.md) | [469](/filings/0000950170-24-090022.md) | [411](/filings/0000950170-24-124196.md) | [509](/filings/0001193125-26-064113.md) | [395](/filings/0000950170-25-062835.md) | [290](/filings/0000950170-25-103114.md) | [275](/filings/0001193125-25-260851.md) | [871](/filings/0001193125-26-340522.md) | [225](/filings/0001193125-26-215064.md) | [181](/filings/0001193125-26-340522.md) |
| Current assets | $m | [5,337](/filings/0000950170-23-058839.md) | [5,572](/filings/0000950170-25-023186.md) | [5,250](/filings/0000950170-24-052961.md) | [5,233](/filings/0000950170-24-090022.md) | [5,183](/filings/0000950170-24-124196.md) | [4,970](/filings/0001193125-26-064113.md) | [4,750](/filings/0000950170-25-062835.md) | [5,143](/filings/0000950170-25-103114.md) | [5,101](/filings/0001193125-25-260851.md) | [5,790](/filings/0001193125-26-340522.md) | [5,063](/filings/0001193125-26-215064.md) | [5,131](/filings/0001193125-26-340522.md) |
| Total assets | $m | [8,589](/filings/0000950170-23-058839.md) | [8,830](/filings/0001193125-26-064113.md) | [8,489](/filings/0000950170-24-052961.md) | [8,454](/filings/0000950170-24-090022.md) | [8,478](/filings/0000950170-24-124196.md) | [8,201](/filings/0001193125-26-064113.md) | [8,037](/filings/0000950170-25-062835.md) | [8,505](/filings/0000950170-25-103114.md) | [8,447](/filings/0001193125-25-260851.md) | [9,160](/filings/0001193125-26-340522.md) | [8,391](/filings/0001193125-26-215064.md) | [8,375](/filings/0001193125-26-340522.md) |
| Current liabilities | $m | [4,428](/filings/0000950170-23-058839.md) | [4,800](/filings/0000950170-25-023186.md) | [4,504](/filings/0000950170-24-052961.md) | [4,578](/filings/0000950170-24-090022.md) | [4,525](/filings/0000950170-24-124196.md) | [4,437](/filings/0001193125-26-064113.md) | [4,239](/filings/0000950170-25-062835.md) | [5,267](/filings/0000950170-25-103114.md) | [5,124](/filings/0001193125-25-260851.md) | [5,234](/filings/0001193125-26-340522.md) | [4,503](/filings/0001193125-26-215064.md) | [4,919](/filings/0001193125-26-340522.md) |
| Long-term debt | $m | not reported | [991](/filings/0000950170-25-023186.md) | not reported | not reported | not reported | [929](/filings/0001193125-26-064113.md) | not reported | not reported | not reported | [1,052](/filings/0001193125-26-064113.md) | not reported | not reported |
| Current portion of debt | $m | [13.6](/filings/0000950170-23-058839.md) | [3.1](/filings/0000950170-25-023186.md) | [15.6](/filings/0000950170-24-052961.md) | [137](/filings/0000950170-24-090022.md) | [24.8](/filings/0000950170-24-124196.md) | [2.4](/filings/0001193125-26-064113.md) | [101](/filings/0000950170-25-062835.md) | [815](/filings/0000950170-25-103114.md) | [748](/filings/0001193125-25-260851.md) | [590](/filings/0001193125-26-064113.md) | [112](/filings/0001193125-26-215064.md) | [476](/filings/0001193125-26-340522.md) |
| Short-term borrowings | $m | not reported | [9.0](/filings/0000950170-25-023186.md) | not reported | not reported | not reported | [21.0](/filings/0001193125-26-064113.md) | not reported | not reported | not reported | [34.6](/filings/0001193125-26-064113.md) | not reported | not reported |
| Shareholders' equity | $m | [2,403](/filings/0000950170-23-058839.md) | [2,223](/filings/0000950170-25-023186.md) | [2,177](/filings/0000950170-24-052961.md) | [2,137](/filings/0000950170-24-090022.md) | [2,176](/filings/0000950170-24-124196.md) | [2,125](/filings/0001193125-26-064113.md) | [2,103](/filings/0000950170-25-062835.md) | [1,994](/filings/0000950170-25-103114.md) | [2,011](/filings/0001193125-25-260851.md) | [2,060](/filings/0001193125-26-340522.md) | [2,065](/filings/0001193125-26-215064.md) | [2,106](/filings/0001193125-26-340522.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent, us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [266 d](/filings/0000950170-24-124196.md) | [114 d](/filings/0001193125-26-064113.md) | [116](/filings/0000950170-25-062835.md) | [(138) d](/filings/0000950170-25-103114.md) | [83.5 d](/filings/0001193125-25-260851.md) | [248 d](/filings/0001193125-26-064113.md) | [(153)](/filings/0001193125-26-215064.md) | [(190) d](/filings/0001193125-26-340522.md) | [59.8 d](/filings/0001193125-25-260851.md) | [179 d](/filings/0001193125-26-064113.md) | [(126)](/filings/0001193125-26-215064.md) | [(2.7) d](/filings/0001193125-26-340522.md) |
| Capital expenditure | $m | [20.5 d](/filings/0000950170-24-124196.md) | [23.1 d](/filings/0001193125-26-064113.md) | [11.8](/filings/0000950170-25-062835.md) | [11.9 d](/filings/0000950170-25-103114.md) | [16.1 d](/filings/0001193125-25-260851.md) | [11.3 d](/filings/0001193125-26-064113.md) | [13.7](/filings/0001193125-26-215064.md) | [17.6 d](/filings/0001193125-26-340522.md) | [15.1 d](/filings/0001193125-25-260851.md) | [10.9 d](/filings/0001193125-26-064113.md) | [9.0](/filings/0001193125-26-215064.md) | [5.8 d](/filings/0001193125-26-340522.md) |
| Dividends paid | $m | [0.0 d](/filings/0000950170-24-124196.md) | [71.2 d](/filings/0001193125-26-064113.md) | not reported | not reported | [0.0 d](/filings/0001193125-25-260851.md) | [72.3 d](/filings/0001193125-26-064113.md) | not reported | not reported | [0.0 d](/filings/0001193125-25-260851.md) | [33.4 d](/filings/0001193125-26-064113.md) | not reported | not reported |
| Share repurchases | $m | [49.9 d](/filings/0000950170-24-124196.md) | [50.0 d](/filings/0001193125-26-064113.md) | [50.0](/filings/0000950170-25-062835.md) | [27.0 d](/filings/0000950170-25-103114.md) | [29.0 d](/filings/0001193125-25-260851.md) | [34.0 d](/filings/0001193125-26-064113.md) | [25.0](/filings/0001193125-26-215064.md) | [13.2 d](/filings/0001193125-26-340522.md) | [0.0 d](/filings/0001193125-25-260851.md) | [0.0 d](/filings/0001193125-26-064113.md) | [0.3](/filings/0001193125-26-215064.md) | [0.0 d](/filings/0001193125-26-340522.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [52.3](/filings/0000950170-23-058839.md) | [51.6](/filings/0000950170-24-052961.md) | [50.7](/filings/0000950170-24-090022.md) | [50.1](/filings/0000950170-24-124196.md) | [48.9](/filings/0000950170-25-062835.md) | [48.4](/filings/0000950170-25-103114.md) | [48.1](/filings/0001193125-25-260851.md) | [47.3](/filings/0001193125-26-215064.md) | [46.5](/filings/0001193125-26-340522.md) | [46.9](/filings/0001193125-25-260851.md) | [47.1](/filings/0001193125-26-215064.md) | [47.4](/filings/0001193125-26-340522.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 46,505,570 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-340522.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.